Zebrafish Il1b Antibody / Interleukin 1 beta (RZ1231),NSJ Bioreagent,RZ1231

Zebrafish IL1B antibody targets interleukin 1 beta Il1b, a pro-inflammatory cytokine essential for innate immune activation, injury responses, and host defense signaling in Danio rerio. Zebrafish, also known as Danio rerio, express il1b as a major effector of the inflammatory cascade, functioning similarly to mammalian interleukin 1 beta. Zebrafish IL1B antibody, also referred to as interleukin 1 beta antibody or Il1b antibody, is widely used to study inflammatory signaling and immune activation in zebrafish models. Il1b is produced primarily by activated macrophages, neutrophils, and epithelial cells following infection, wounding, or exposure to inflammatory stimuli. Once synthesized as an inactive precursor, Il1b undergoes proteolytic cleavage to generate a mature secreted cytokine that triggers broad transcriptional and cellular immune responses.Il1b belongs to the interleukin 1 family of cytokines that act as key upstream regulators of inflammation. In zebrafish larvae, il1b expression is rapidly induced following tissue damage, bacterial exposure, or pro-inflammatory signaling through pathways such as NF-kappaB, MyD88, and inflammasome-associated caspases. A Zebrafish IL1B antibody is suitable for research applications examining inflammatory zone formation, innate immune activation, and cytokine localization patterns during early development or experimental immune challenges.Functionally, Il1b drives early immune cell recruitment and activation. Upon release, Il1b promotes neutrophil migration to sites of injury, enhances macrophage activation, and stimulates the expression of downstream cytokines and chemokines. In zebrafish models, il1b induction is frequently used as a sensitive marker for inflammation, infection, or toxicant exposure. Il1b also influences tissue remodeling, cellular proliferation, and metabolic responses during inflammatory episodes. Because zebrafish show strong and trackable innate immune responses, Il1b is widely studied in models of wound healing, pathogen infection, environmental stress, and inflammatory disease.Structurally, zebrafish Il1b is synthesized as a pro-peptide containing an N-terminal region that must be removed by proteolytic processing to generate the active cytokine. Its mature form is secreted into extracellular spaces, where it binds to interleukin 1 receptors and activates downstream signaling cascades. Zebrafish il1b maps to chromosome 19, with regulatory elements allowing rapid transcriptional upregulation in response to injury and immune activation. Co-localization studies often detect Il1b in macrophages and neutrophils at wound margins, infection sites, or inflamed tissues, frequently overlapping with markers of innate immune activation such as mpo, mpeg1.1, or tnfa.A Zebrafish IL1B antibody is suitable for detecting Il1b in studies focused on inflammation, innate immune signaling, host-pathogen interactions, and tissue injury responses in Danio rerio. Its secreted and pericellular distribution provides insight into cytokine-driven communication networks that coordinate immune cell behavior. Researchers utilize Il1b expression patterns to investigate the timing of inflammatory signaling, assess immune dysregulation, characterize mutant immune phenotypes, and evaluate responses to environmental or chemical stressors. These features make this antibody a valuable tool for research in vertebrate immunology, inflammatory biology, and developmental immune system function, and it is supplied for research use by NSJ Bioreagents.This Zebrafish antibody is part of abroader Zebrafish / Danio rerio antibody paneloffered by NSJ Bioreagents.